These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6796504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [Abstract] [Full Text] [Related]

  • 3. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J, Monsalve Rodríguez M, Gómez Cisneros S, García Alonso J.
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G.
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract] [Full Text] [Related]

  • 6. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Mar; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 7. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Mar; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 8. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC.
    Prog Clin Biol Res; 1984 Mar; 153():275-85. PubMed ID: 6433356
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK, Sen DK.
    J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M, Caro Cebrián C, Sanz Vélez JI, Roncalés A, Rioja Sanz C.
    Actas Urol Esp; 1981 Nov 01; 5(4):219-22. PubMed ID: 6797270
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rationale for intensive intravesical chemotherapy.
    Soloway MS.
    Prog Clin Biol Res; 1984 Nov 01; 153():287-95. PubMed ID: 6433357
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravesical treatment with thiotepa: an update review.
    Fosså SD.
    Prog Clin Biol Res; 1984 Nov 01; 162B():163-8. PubMed ID: 6438640
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D, Blackard C.
    Urology; 1977 Dec 01; 10(6):556-61. PubMed ID: 414402
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.